Prolonged Infusions of Meropenem in Pediatric Infections with Carbapenem Resistant Gram Negative Bacteria

In many pediatric wards, infections caused by GNB are increasingly resulting in significant morbidity and mortality. For the infections with CR-GNB, a choice of treatment in children is prolonged infusions of carbapenem, particularly the meropenem. To assess the effectiveness of prolonged meropenem...

Full description

Saved in:
Bibliographic Details
Main Authors: Sevgen Tanır Basaranoglu, Ayşe Istanbullu
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Journal of Global Antimicrobial Resistance
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2213716524002224
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846106899629473792
author Sevgen Tanır Basaranoglu
Ayşe Istanbullu
author_facet Sevgen Tanır Basaranoglu
Ayşe Istanbullu
author_sort Sevgen Tanır Basaranoglu
collection DOAJ
description In many pediatric wards, infections caused by GNB are increasingly resulting in significant morbidity and mortality. For the infections with CR-GNB, a choice of treatment in children is prolonged infusions of carbapenem, particularly the meropenem. To assess the effectiveness of prolonged meropenem infusion (PMI) in children with carbapenem resistant (CR) Gram negative bacteria (GNB) infections.The present study included pediatric patients between 1 month and 18 years of age who were hospitalised and presented with bacteremia with a positive blood culture with CR-GNB. We analysed the causative microorganism, susceptibility profile, the antimicrobials used in combination with PMI. Outcome measures were negative blood culture 14-day and 30-day mortality, and recurrence of infection in 14 days of completion of treatment.Between Jun 2022 and July 2024, a total of 19 (10 male, 9 female) children with 26 infections were recorded. The most common underlying disease was hemato-oncological disease, followed by chronic lung disease. Among the causative microorganisms, n=16 (61%) {Klebsiella} spp, n=7 (27%) {Pseudomonas} spp., n=1 (3.8%) {Ochromobacter} spp, n=1 (3.8%) {E. coli } were detected. Three infections recurred in the 14 days of completion of treatment. Seven (36.8%) patients died within 14 days of infection. Four of the patients who died had bone marrow transplant, one had chronic pulmonary disease, one with renal transplantation, and one had operated congenital heart effect.In pediatric infections with CR-GNB, PMI in combination with other GNB-active agents may be a reasonable choice. The mortality is closely related to the underlying disease and immune status.
format Article
id doaj-art-0ade5cf0770c49de8ff8b22921e1e040
institution Kabale University
issn 2213-7165
language English
publishDate 2024-12-01
publisher Elsevier
record_format Article
series Journal of Global Antimicrobial Resistance
spelling doaj-art-0ade5cf0770c49de8ff8b22921e1e0402024-12-27T04:08:19ZengElsevierJournal of Global Antimicrobial Resistance2213-71652024-12-01391415Prolonged Infusions of Meropenem in Pediatric Infections with Carbapenem Resistant Gram Negative BacteriaSevgen Tanır Basaranoglu0Ayşe Istanbullu1Istanbul Medipol University, Faculty of Medicine, Pediatric Infectious DiseasesIstanbul Medipol University, Faculty of Medicine, MicrobiologyIn many pediatric wards, infections caused by GNB are increasingly resulting in significant morbidity and mortality. For the infections with CR-GNB, a choice of treatment in children is prolonged infusions of carbapenem, particularly the meropenem. To assess the effectiveness of prolonged meropenem infusion (PMI) in children with carbapenem resistant (CR) Gram negative bacteria (GNB) infections.The present study included pediatric patients between 1 month and 18 years of age who were hospitalised and presented with bacteremia with a positive blood culture with CR-GNB. We analysed the causative microorganism, susceptibility profile, the antimicrobials used in combination with PMI. Outcome measures were negative blood culture 14-day and 30-day mortality, and recurrence of infection in 14 days of completion of treatment.Between Jun 2022 and July 2024, a total of 19 (10 male, 9 female) children with 26 infections were recorded. The most common underlying disease was hemato-oncological disease, followed by chronic lung disease. Among the causative microorganisms, n=16 (61%) {Klebsiella} spp, n=7 (27%) {Pseudomonas} spp., n=1 (3.8%) {Ochromobacter} spp, n=1 (3.8%) {E. coli } were detected. Three infections recurred in the 14 days of completion of treatment. Seven (36.8%) patients died within 14 days of infection. Four of the patients who died had bone marrow transplant, one had chronic pulmonary disease, one with renal transplantation, and one had operated congenital heart effect.In pediatric infections with CR-GNB, PMI in combination with other GNB-active agents may be a reasonable choice. The mortality is closely related to the underlying disease and immune status.http://www.sciencedirect.com/science/article/pii/S2213716524002224Pediatricprolonged meropenem infusiondrug resistant Gram negative bacteria
spellingShingle Sevgen Tanır Basaranoglu
Ayşe Istanbullu
Prolonged Infusions of Meropenem in Pediatric Infections with Carbapenem Resistant Gram Negative Bacteria
Journal of Global Antimicrobial Resistance
Pediatric
prolonged meropenem infusion
drug resistant Gram negative bacteria
title Prolonged Infusions of Meropenem in Pediatric Infections with Carbapenem Resistant Gram Negative Bacteria
title_full Prolonged Infusions of Meropenem in Pediatric Infections with Carbapenem Resistant Gram Negative Bacteria
title_fullStr Prolonged Infusions of Meropenem in Pediatric Infections with Carbapenem Resistant Gram Negative Bacteria
title_full_unstemmed Prolonged Infusions of Meropenem in Pediatric Infections with Carbapenem Resistant Gram Negative Bacteria
title_short Prolonged Infusions of Meropenem in Pediatric Infections with Carbapenem Resistant Gram Negative Bacteria
title_sort prolonged infusions of meropenem in pediatric infections with carbapenem resistant gram negative bacteria
topic Pediatric
prolonged meropenem infusion
drug resistant Gram negative bacteria
url http://www.sciencedirect.com/science/article/pii/S2213716524002224
work_keys_str_mv AT sevgentanırbasaranoglu prolongedinfusionsofmeropeneminpediatricinfectionswithcarbapenemresistantgramnegativebacteria
AT ayseistanbullu prolongedinfusionsofmeropeneminpediatricinfectionswithcarbapenemresistantgramnegativebacteria